BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18680075)

  • 1. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
    Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
    Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
    Sudhindran S; Bromwich E; Edwards PR
    Br J Surg; 2001 Sep; 88(9):1178-82. PubMed ID: 11531863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
    Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
    Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
    N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
    Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial.
    Dumot JA; Conwell DL; O'Connor JB; Ferguson DR; Vargo JJ; Barnes DS; Shay SS; Sterling MJ; Horth KS; Issa K; Ponsky JL; Zuccaro G
    Am J Gastroenterol; 1998 Jan; 93(1):61-5. PubMed ID: 9448176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial.
    Romagnuolo J; Hilsden R; Sandha GS; Cole M; Bass S; May G; Love J; Bain VG; McKaigney J; Fedorak RN
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):465-71; quiz 371. PubMed ID: 18304883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial.
    Nøjgaard C; Hornum M; Elkjaer M; Hjalmarsson C; Heyries L; Hauge T; Bakkevold K; Andersen PK; Matzen P;
    Gastrointest Endosc; 2009 May; 69(6):e31-7. PubMed ID: 19410035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
    Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
    Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
    Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M
    Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis.
    Dumot JA; Conwell DL; Zuccaro G; Vargo JJ; Shay SS; Easley KA; Ponsky JL
    Am J Gastroenterol; 2001 Jul; 96(7):2098-102. PubMed ID: 11467638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Khoshbaten M; Khorram H; Madad L; Ehsani Ardakani MJ; Farzin H; Zali MR
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e11-6. PubMed ID: 17683501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
    Masci E; Cavallini G; Mariani A; Frulloni L; Testoni PA; Curioni S; Tittobello A; Uomo G; Costamagna G; Zambelli S; Macarri G; Innocenti P; Dragonetti C;
    Am J Gastroenterol; 2003 Oct; 98(10):2182-6. PubMed ID: 14572565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
    Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
    Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.